Technology is improving at a faster pace and so does their upgraded devices. Apple has recently joined hands with a Pharmaceutical company, Eli Lilly along with a start-up Evidation. Apple along with these two companies will be helping their owners with various health-related benefits.
According to one of their reports, Evidation co-founder Christine Lemke says- “With this research, we looked at how everyday behavior data, such as those captured by iPhone, Apple Watches, and Beddit sleep monitors, may be effective in differentiating between individuals with mild cognitive impairment and early Alzheimer’s disease, and those without symptoms.”
The study came to a conclusion keeping in mind 113 people on hand, who were provided with an iPhone along with a sleep-tracker to track their sleep cycle. It has been noticed after 12 weeks that 31 people out of 113 were suffering from dementia and various other cognitive ailments. There were various others who were tested against a controlled group of 82 people. These subjects were asked to keep themselves away from any kind of medications in the process of the test.
There are special sensors installed in iPhones which allows them to track their steps taken along with the handset which will be now used for daily surveys.
Divakar Ramakrishnan, Ph.D., chief digital officer, Lilly says- “Lilly has been leading the fight against Alzheimer’s disease for more than 30 years, and we’re broadening the application of digital health to identify tools that may improve the lives of people with chronic conditions and diseases. While further research is needed, the study findings provide important insight into the potential benefits of wearable devices and dementia. These findings could inform subsequent research that may eventually lead to early screening or detection tools for neurodegenerative conditions.”